MyFinsight
Home
About
Contact
spry: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, SPRY has $372,803K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
372,803
313,472
Total stockholders' equity
147,655
192,321
Total liabilities and stockholders' equity
372,803
313,472
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$6,421K
Inventories
$7,782K
Accounts receivable, net
$36,451K
Short-term investments
$228,652K
Cash and cash
equivalents
$59,557K
Other assets
$2,918K
Intangible assets, net
$14,729K
Fixed assets, net
$1,209K
Right-of-use asset
$1,439K
Long-term inventories
$13,645K
Total current assets
$338,863K
Total assets
$372,803K
Total liabilities and
stockholders' equity
$372,803K
Total stockholders'
equity
$147,655K
Total liabilities
$225,148K
Accumulated deficit
-$253,279K
Accumulated other
comprehensive (loss) gain, net
-$7K
Additionalpaid-incapital
$400,931K
Other accrued
liabilities
$3,781K
Lease liability, net
of current portion
$949K
Contract liability, net
of current portion
$1,268K
Financing liability
$72,044K
Term loans, net
(including related party...
$96,229K
Total current
liabilities
$50,877K
Common stock, 0.0001
par value per share...
$10K
Lease liability,
current
$583K
Contract liability,
current
$526K
Accounts payable and
accrued liabilities...
$49,768K
Buy me a coffee
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)